Form D · Other Technology

Cancer IQ Inc.

Chicago, IL · CIK 0001810038

Offering snapshot reported May 26, 2026 · SEC filing

Reported sold: $4.28M
Investors reported: 9
Minimum accepted: $0
First sale: Nov 1, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$3,350,000 → $4,284,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 26, 2026	Amendment	$4,284,000	$934,000vs Nov 13, 2023	9	SEC filing
Nov 13, 2023	Initial	$3,350,000	No comparison	9	SEC filing
Apr 8, 2022	Initial	$14,000,293	No comparison	6	SEC filing
Apr 23, 2020	Initial	$1,620,700	No comparison	5	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-496976

Source: Form D, filed May 26, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Olufeyikemi Olopade Ayodele	Director, Executive
Mark Bakken	Director
Christopher Bun	Executive
Paul Burton	Executive
Jordan Dolin	Director
Carladenise Edwards	Director
Joel Krikston	Director
Haibo Lu	Director, Executive
Andrea Metkus	Director
Olufunmilayo Olapade	Director
Evan Wood	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

2045 W Grand Avenue Ste B Pmb 404765
Chicago, IL, 60612